ClinicalTrials.gg
RecruitingNCT07316933Updated Jun 10, 2026

Acute Exercise Responses With Blood Flow Restriction Under Dynamic Pressure Compared to Fixed Pressure in Patients With Severe Gonarthrosis

An interventional study of Low-intensity resistance exercise with moderate arterial occlusion pressure and dynamic pressure. and Low-intensity resistance exercise with moderate arterial occlusion pressure and fixed pressure. in Severe Knee Osteoarthritis, sponsored by University of Valencia. Recruiting at 1 site in Spain. Open to participants aged 50 Years to 85 Years. Per ClinicalTrials.gov, last updated 2026-06-10.

Sponsored by University of Valencia · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Mar 2026; still recruiting 8 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
45
Allocation
Randomized
Ages
50 Years to 85 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 11 studies in Osteoarthritis, Knee by University of Valencia — 2 open to participants now, 2 under way, none of them phase 3. Osteoarthritis, Knee · University of Valencia.

Planned enrollment
6th of 10
45 · median 48
Started
2026
with 1 other
No phase
10 of 11
2 open now
Registered
10th of 11
by date

Among the 11 studies in Osteoarthritis, Knee by University of Valencia, this one is the 6th largest by planned enrollment of the 10 interventional ones that give a count, is one of 2 that started in 2026, is one of 10 with no phase, and was the 10th registered.

Osteoarthritis, Knee

3,297 studies on the registry are indexed under Osteoarthritis, Knee; 623 are open to participants now.

Browse Osteoarthritis, Knee studies →

Open to participants now

2 of the 11 studies in Osteoarthritis, Knee by University of Valencia are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 2 open studies →

Where they have run

Who these studies take

Of the 384 Osteoarthritis, Knee studies recruiting now, 178 (46%) set no upper age limit and 113 (29%) stop at 75 or younger; 19 take children under 18; 39 take healthy volunteers.

This study: 50 Years to 85 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 11 studies in Osteoarthritis, Knee by University of Valencia, or all of them as a file.
02

Study summary

This study aims to evaluate the acute effects of blood flow restriction (BFR) training on hypoalgesia and neuromuscular responses in patients with severe gonarthrosis by comparing the application of pressure with a dynamic versus a fixed configuration. There will be six different training conditions with varying levels of blood flow occlusion (%BFR) and percentage of load (%RM): 1) 30% RM and 50% BFR with dynamic pressure; 2) 30% RM and 50% BFR with fixed pressure; 3) 50% RM and 50% BFR with dynamic pressure; 4) 50% RM and 50% BFR with fixed pressure; 5) 30% RM and 80% BFR with dynamic pressure; 6) 30% RM and 80% BFR with fixed pressure.

Each participant will complete six individual sessions under different training conditions, assigned in a random order with a 72-hour interval between each session.

03

Conditions studied

  • Severe Knee Osteoarthritis

Keywords

  • blood flow restriction
  • exercise
  • gonarthrosis
04

Who can participate

Ages eligible
50 Years to 85 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age between 50 and 85 years
  • Diagnosis of severe gonarthrosis according to the clinical and radiographic criteria of the American College of Rheumatology guidelines.
  • On the waiting list for unilateral total knee replacement (TKR) surgery

Exclusion criteria

Exclusion Criteria:

  • Pain in the contralateral leg with an intensity ≥80/100 mm on the visual analog scale (VAS) during daily activities.
  • Previous hip or knee replacement surgery and osteotomy within the last year.
  • arthritis
  • Medical conditions that contraindicate exercise.
  • Participation in exercise programs (>2 days/week with training at intensities of 10-15 1RM) in the previous six months.
  • History of stroke, brain surgery, major depression, or self-reported cognitive impairment that could affect performance in the study.
  • Cardiovascular, thrombotic, or vascular risk factors (uncontrolled hypertension, peripheral arterial disease, history of deep vein thrombosis or pulmonary embolism, heart failure, severe varicose veins, or uncontrolled anticoagulant therapy).
  • Skin or local alterations at the cuff application site (ulcers, open wounds, infections, lymphedema, or severe edema).
  • Inability to communicate normally or with impaired communication skills.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Autoimmune disease

A condition in which the immune system attacks the body’s own tissues, such as rheumatoid arthritis, lupus, psoriasis, type 1 diabetes or inflammatory bowel disease.

Immunotherapy studies often leave out active autoimmune disease, and some name exceptions, such as thyroid disease on replacement hormone. Check the exceptions this study lists.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
45 participants (estimated)

Study arms

  • Experimental
    Low-load resistance exercise with moderate blood occlusion and dynamic pressure.

    A single session of exercise, 30% repetition maximum, 50% blood occlusion, and dynamic pressure

    Device: Moderate-intensity resistance exercise with low arterial occlusion pressure and dynamic pressure.

  • Experimental
    Low-load resistance exercise with moderate blood occlusion and fixed pressure.

    A single session of exercise, 30% repetition maximum, 50% blood occlusion, and fixed pressure

    Device: Moderate-intensity resistance exercise with low arterial occlusion pressure and fixed pressure.

  • Experimental
    Moderate-load resistance exercise with low blood occlusion and dynamic pressure.

    A single session of exercise, 50% repetition maximum, 30% blood occlusion, and dynamic pressure

    Device: Low-intensity resistance exercise with high arterial occlusion pressure and dynamic pressure.

  • Experimental
    Moderate-load resistance exercise with low blood occlusion and fixed pressure.

    A single session of exercise, 50% repetition maximum, 30% blood occlusion, and fixed pressure

    Device: Low-intensity resistance exercise with high arterial occlusion pressure and fixed pressure.

  • Experimental
    Low-load resistance exercise with high blood occlusion and dynamic pressure

    A single session of exercise, 15% repetition maximum, 80% blood occlusion, and dynamic pressure

    Device: Low-intensity resistance exercise with moderate arterial occlusion pressure and dynamic pressure.

  • Experimental
    Low-load resistance exercise with high blood occlusion and fixed pressure

    A single session of exercise, 15% repetition maximum, 80% blood occlusion, and fixed pressure

    Device: Low-intensity resistance exercise with moderate arterial occlusion pressure and fixed pressure.

Interventions

  • DeviceLow-intensity resistance exercise with moderate arterial occlusion pressure and dynamic pressure.

    A single quadriceps extension exercise at 30% of 1 repetition maximum (1RM) with dynamic occlusion at 50% of limb occlusion pressure (LOP), performing 4 sets of 30, 15, 15, 15 repetitions with 30 seconds of rest between sets.

  • DeviceLow-intensity resistance exercise with moderate arterial occlusion pressure and fixed pressure.

    A single quadriceps extension exercise at 30% of 1RM with fixed occlusion at 50% of limb occlusion pressure (LOP), performing 4 sets of 30, 15, 15, 15 repetitions with 30 seconds of rest between sets.

  • DeviceModerate-intensity resistance exercise with low arterial occlusion pressure and dynamic pressure.

    A single quadriceps extension exercise at 50% of 1RM with dynamic occlusion at 30% of limb occlusion pressure (LOP), performing 4 sets of 30, 15, 15, 15 repetitions with 30 seconds of rest between sets.

  • DeviceModerate-intensity resistance exercise with low arterial occlusion pressure and fixed pressure.

    A single quadriceps extension exercise at 50% of 1RM with a fixed occlusion of 30% of the limb occlusion pressure (LOP), performing 4 sets of 30, 15, 15, 15 repetitions with 30 seconds of rest between sets.

  • DeviceLow-intensity resistance exercise with high arterial occlusion pressure and dynamic pressure.

    A single quadriceps extension exercise at 15% of 1RM with a dynamic occlusion of 80% of the limb occlusion pressure (LOP), performing 4 sets of 30, 15, 15, 15 repetitions with 30 seconds of rest between sets.

  • DeviceLow-intensity resistance exercise with high arterial occlusion pressure and fixed pressure.

    A single quadriceps extension exercise at 15% of 1RM with a fixed occlusion of 80% of the limb occlusion pressure (LOP), performing 4 sets of 30, 15, 15, 15 repetitions with 30 seconds of rest between sets.

06

What researchers measure

Primary outcomes

  1. Pain intensity at rest (Visual Analogue Scale, 0-10)

    Pain intensity perceived on a Visual Analogue Scale, at rest, being 0 no pain and 10 the worst pain imaginable.

    Time frame: Periprocedural

Secondary outcomes

  1. Pressure pain threshold

    Pressure pain threshold measured in the middle deltoid (peripheral sensitivity) and tibialis anterior (central sensitivity), using an algometer

    Time frame: Periprocedural

  2. Perceived exertion scale (The BORG CR10 Scale)

    The BORG CR10 Scale is a subjective tool used to measure the intensity of the perceived exertion of a person during an activity through a rate of perceived exertion (RPE). It is scored on a scale of 0 to 10, where 0 is no exertion and 10 is maximum exertion.

    Time frame: Periprocedural

  3. Surface electromyography

    Surface electromyography for the study of muscle recruitment (vastus medialis and vastus lateralis)

    Time frame: Periprocedural

  4. Occurrence of adverse effects

    Occurrence of adverse effects (e.g., pain, delayed onset muscle soreness, sudden weakness of the trained limb, redness or swelling of the trained limb, etc.) by self-report.

    Time frame: Immediately after the intervention, 72 hours later, and two weeks after the study ended.

  5. Kinesiophobia (The Tampa Scale for Kinesiophobia)

    The Tampa Scale for Kinesiophobia is a questionnaire designed to assess fear of movement and avoidance of physical activity due to pain. It consists of 17 items answered on a scale of 1 (strongly disagree) to 4 (strongly agree), measuring two main factors: fear of movement and activity avoidance. The total score ranges from 17 to 68 points, with higher scores indicating greater kinesophobia.

    Time frame: Baseline

  6. Pain catastrophizing

    The Pain Catastrophizing Scale includes 13 items in total (0-52 points) that describe different thoughts and feelings associated with pain. The PCS consists of 5 grades: 0 not at all, 1 a little, 2 moderately, 3 a lot, and 4 always. The participant must mark their situation for each case. Higher scores correspond to higher levels of pain catastrophizing

    Time frame: Baseline

  7. Functional Measure (Western Ontario and McMaster Universities Osteoarthritis Index)

    The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) is a questionnaire designed to assess pain, stiffness, and function in patients with knee and hip osteoarthritis. It consists of 24 items, divided into three subscales that assess pain (5 items), stiffness (2 items), and physical function (17 items). Responses are given on a 0-to-4 Likert-type scale, where higher scores indicate greater impairment.

    Time frame: Baseline

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No — The data that support the findings of this study will be available from the corresponding author upon reasonable request.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Mar 2026 (actual). Primary completion is estimated for Dec 2027, 21 months after the start.

Of 1,114 non-industry interventional studies with no phase under Osteoarthritis, Knee, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 36. This study's planned 21 months is above that.

Counting every sponsor, half of 1,253 studies reached it within 18 months; a quarter within 8 and three quarters within 36.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 9, 2025
First posted
Jan 5, 2026
StartActual
Mar 1, 2026
Primary completionEst.
Dec 2027
CompletionEst.
Dec 2027
Last update
Jun 10, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 10, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07316933
Responsible party
Adrián Escriche Escuder (Assistant professor, University of Valencia) — Principal investigator
First posted
Jan 5, 2026
Start date
Mar 1, 2026
Primary completion
Dec 2027 (estimated)
Completion
Dec 2027 (estimated)
Last update
Jun 10, 2026

Study contacts

Adrián Escriche-Escuder, PhD
Contact
adrian.escriche@uv.es
+34 963 98 38 55

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion